| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Corporate Controller
1 company
Bulis Veronica Sanchez is a VP, Corporate Controller at Lyell Immunopharma, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $190K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 254 | $23.12 | $5,872.48 | -1.6% | -18.5% | - | |
| Dec 30, 2025 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 2,072 | $35.80 | $74,180.64 | -12.0% | -38.9% | - | |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 239 | $16.10 | $3,847.90 | -2.5% | +31.5% | - |